RAMAZZOTTI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 4.277
EU - Europa 3.424
AS - Asia 3.004
AF - Africa 333
SA - Sud America 181
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.236
Nazione #
US - Stati Uniti d'America 4.240
SG - Singapore 1.063
IT - Italia 965
CN - Cina 846
GB - Regno Unito 603
VN - Vietnam 486
DE - Germania 477
SE - Svezia 446
HK - Hong Kong 215
RU - Federazione Russa 164
IN - India 146
BR - Brasile 120
FR - Francia 116
IE - Irlanda 110
TG - Togo 109
UA - Ucraina 109
KR - Corea 98
NL - Olanda 84
CI - Costa d'Avorio 76
FI - Finlandia 71
SC - Seychelles 56
ZA - Sudafrica 45
CH - Svizzera 43
EE - Estonia 41
BG - Bulgaria 40
AT - Austria 37
NG - Nigeria 37
JP - Giappone 33
HR - Croazia 29
AR - Argentina 26
BE - Belgio 24
CA - Canada 24
ID - Indonesia 20
PK - Pakistan 19
PL - Polonia 19
JO - Giordania 18
GR - Grecia 12
RO - Romania 11
ES - Italia 10
UY - Uruguay 10
BD - Bangladesh 9
MY - Malesia 8
EC - Ecuador 7
MX - Messico 7
TR - Turchia 7
AU - Australia 6
CL - Cile 5
CO - Colombia 5
IQ - Iraq 5
NZ - Nuova Zelanda 5
UZ - Uzbekistan 5
TH - Thailandia 4
KZ - Kazakistan 3
PE - Perù 3
PY - Paraguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AM - Armenia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
LB - Libano 2
MA - Marocco 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
SS - ???statistics.table.value.countryCode.SS??? 2
TN - Tunisia 2
AL - Albania 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
HN - Honduras 1
KW - Kuwait 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
NI - Nicaragua 1
NP - Nepal 1
NR - Nauru 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SA - Arabia Saudita 1
SV - El Salvador 1
VE - Venezuela 1
WS - Samoa 1
Totale 11.236
Città #
Singapore 718
Southend 519
Ashburn 467
Chandler 429
Fairfield 427
Bologna 331
Santa Clara 241
Houston 233
Hong Kong 212
Woodbridge 185
Ann Arbor 184
Hefei 179
Seattle 176
Cambridge 157
Wilmington 157
Princeton 138
Beijing 122
Boardman 114
Dallas 111
Dublin 110
Lomé 109
Dong Ket 102
Ho Chi Minh City 93
Abidjan 76
Seoul 69
Frankfurt am Main 65
Jacksonville 63
Hanoi 58
Westminster 56
New York 54
Nanjing 53
Milan 51
Padova 49
Berlin 44
Helsinki 43
Los Angeles 41
Sofia 40
Munich 38
Bern 37
San Diego 37
Florence 36
Abeokuta 35
Turin 33
Buffalo 32
Moscow 32
Saint Petersburg 32
Tokyo 32
Jinan 31
Redondo Beach 29
Redwood City 25
Redmond 24
Shenyang 24
Vienna 24
Brussels 23
Rome 23
Bremen 22
Changsha 22
São Paulo 22
Guangzhou 20
Parma 19
Shanghai 19
San Francisco 18
Sejong 18
Amman 17
Des Moines 17
Medford 16
Nanchang 16
Udine 16
London 15
Bengaluru 14
Chicago 14
Jakarta 14
Lappeenranta 14
Turku 14
Tianjin 13
Warsaw 13
Nuremberg 12
Hebei 11
Kunming 11
Mountain View 11
Zhengzhou 11
Dearborn 10
Falkenstein 10
Mülheim 10
Rawalpindi 10
Verona 10
Boston 9
Falls Church 9
Forlì 9
Locri 9
Olalla 9
Haiphong 8
Hangzhou 8
Jiaxing 8
Mahé 8
Montevideo 8
Norwalk 8
Stockholm 8
Toronto 8
Biên Hòa 7
Totale 7.398
Nome #
Cell signaling pathways in autosomal-dominant leukodystrophy (ADLD): the intriguing role of the astrocytes 304
Lamin A and prelamin A counteract invasiveness of osteosarcoma cells 237
A role for PKCepsilon during C2C12 myogenic differentiation 222
Impact of phospholipase C β1 in glioblastoma: a study on the main mechanisms of tumor aggressiveness 216
Inositide-Dependent Nuclear Signalling in Health and Disease 212
Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. 201
BMP-2 Induced Expression of PLCβ1 That is a Positive Regulator of Osteoblast Differentiation 194
Nuclear inositide signaling and cell cycle 194
K562 cell proliferation is modulated by PLCbeta1 through a PKCalpha-mediated pathway 191
PLC-β1 and cell differentiation: An insight into myogenesis and osteogenesis 190
Aberrant expression of B203.13 antigen in acute lymphoid leukemia of B-cell origin. 183
Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes 182
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells. 182
Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS 181
Cancer therapy and treatments during COVID-19 era 181
Revisiting nuclear phospholipase C signalling in MDS 177
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 177
Phospholipases in Gliomas: Current Knowledge and Future Perspectives from Bench to Bedside 175
Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes 175
Nuclear phospholipase C isoenzyme imbalance leads to pathologies in brain, hematologic, neuromuscular, and fertility disorders 175
An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes 174
Genotype of inflammatory cytokines in limbal stem cell graft in Italian patients. 173
Inositide signaling in the nucleus: From physiology to pathology. 173
Nuclear Inositide Signaling via Phospholipase C 171
The wide and growing range of lamin B‑related diseases: from laminopathies to cancer 168
eEF1A phosphorylation in the nucleus of insulin-stimulated C2C12 myoblasts: Ser53 is a novel substrate for protein kinase C βI 166
Location-dependent role of phospholipase C signaling in the brain: Physiology and pathology 165
Anticancer agents sensitize osteosarcoma cells to TNF-related apoptosis-inducing ligand downmodulating IAP family proteins. 163
Role of PLCγ1 in the modulation of cell migration and cell invasion in glioblastoma 163
Lamin B1 accumulation’s effects on autosomal dominant leukodystrophy (ADLD): Induction of reactivity in the astrocytes 162
Nuclear phospholipase C beta1 and cellular differentiation. 161
IPMK and β-catenin mediate PLC-β1-dependent signaling in myogenic differentiation 159
Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome. 157
Epigenetic regulation of nuclear inositide signalling in high-risk MDS patients 157
Nuclear Phosphatidylinositol Signaling: Focus on Phosphatidylinositol Phosphate Kinases and Phospholipases C 152
Phosphoinositide-dependent signaling in cancer: A focus on phospholipase C isozymes 152
Physiology and pathology of nuclear phospholipase C beta1 150
Therapeutic potential of nvp-bkm120 in human osteosarcomas cells 150
Structural Variants at the LMNB1 Locus: Deciphering Pathomechanisms in Autosomal Dominant Adult-Onset Demyelinating Leukodystrophy 149
Involvement of nuclear PLC{beta}1 in lamin B1 phosphorylation and G2/M cell cycle progression. 147
Nuclear PI-PLCβ1 and Myelodysplastic Syndromes: Genetics and Epigenetics 147
Inositide-dependent phospholipase C signaling mimics insulin in skeletal muscle differentiation by affecting specific regions of the cyclin D3 promoter 146
Phospholipase C-β1 interacts with cyclin E in adipose- derived stem cells osteogenic differentiation 146
null 144
MiRNA-210: A Current Overview 143
Subcellular localization relevance and cancer-associated mechanisms of diacylglycerol kinases 143
Advances in MDS/AML and inositide signalling 142
Modulation of nuclear PI-PLCbeta1 during cell differentiation 140
The physiology and pathology of inositide signaling in the nucleus 140
Nuclear inositide signaling in myelodysplastic syndromes. 139
Lamin B1 as a key modulator of the developing and aging brain 138
Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes 137
Nuclear PI-PLCbeta1-Lamin B1 complex signalling during cell cycle progression in human erytholeukemia cells 133
PLC-beta 1 regulates the expression of miR-210 during mithramycin-mediated erythroid differentiation in K562 cells 132
Role of nuclear PLC and PI3K signaling in the development of cancer 132
Recent advances in MDS mutation landscape: Splicing and signalling 132
Nuclear Phosphoinositides as Key Determinants of Nuclear Functions 131
Epigenetic regulation of nuclear PLCbeta1 and Cyclin D3 during Azacitidine treatment 129
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. 127
Nuclear translocation of PKCα isoenzyme is involved in neurogenic commitment of human neural crest-derived periodontal ligament stem cells 125
Phosphoinositide 3 Kinase signaling in human stem cells from reprogramming to differentiation: A tale in cytoplasmic and nuclear compartments 124
Understanding the Ultra-Rare Disease Autosomal Dominant Leukodystrophy: an Updated Review on Morpho-Functional Alterations Found in Experimental Models 122
A novel DAG-dependent mechanism links PKCɑ and Cyclin B1 regulating cell cycle progression 122
Roles of PI3K/AKT/mTOR Axis in Arteriovenous Fistula 117
Signaling pathways and bone marrow microenvironment in myelodysplastic neoplasms 116
Nuclear PI-PLC β1 and Myelodysplastic Syndromes: From Bench to Clinics 115
Deciphering signaling pathways in hematopoietic stem cells: the molecular complexity of Myelodysplastic Syndromes (MDS) and leukemic progression 107
Nuclear PLCs affect insulin secretion by targeting PPARgamma; in pancreatic beta cells. 107
IPMK and β-catenin take part in PLC-β1-dependent signaling pathway during myogenic differentiation 100
Roles of p53, NF-kappa B and the androgen receptor in controlling NGAL expression in prostate cancer cell lines 82
null 80
null 78
Nuclear phosphoinositides: location, regulation and function. 73
Phosphatidylinositol Turnover and Receptors 68
null 65
Nuclear phospholipase C in biological control and cancer 52
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells 49
Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology. 40
Totale 11.524
Categoria #
all - tutte 31.740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.740


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021627 0 0 0 0 0 58 40 71 86 51 42 279
2021/20221.581 155 35 109 113 133 70 42 99 46 262 266 251
2022/20231.798 199 243 106 254 151 133 119 85 258 32 105 113
2023/2024658 26 91 83 64 69 105 40 31 32 38 31 48
2024/20252.034 87 253 209 127 336 108 188 97 49 112 106 362
2025/20262.320 385 495 424 302 559 155 0 0 0 0 0 0
Totale 11.524